A machine learning-based framework for prognostic prediction and tumor microenvironment characterization of locally advanced cervical cancer with concurrent chemoradiotherapy
Accurate prognosis prediction for locally advanced cervical cancer (LACC) after concurrent chemoradiotherapy (CCRT) is essential for individualized treatment decision making. We aimed to develop a multitask prognostic model and reveal radiomic-phenotypic associations for LACC patients after CCRT. The framework consists of (1) A deep learning-based fully automated model (DeepMR-LACC) which used T2-weighted magnetic resonance images obtained before CCRT to predict patient outcomes; (2) Proteomics profiling from paired cervical biopsy samples for tumor microenvironment characterization and radioproteomics-based risk stratification. The DeepMR-LACC predicted progression-free survival (PFS) and overall survival (OS) in training [C-indices, 0.80 (95% confidence interval, 0.75-0.84) and 0.83 (0.80-0.87)], internal test [0.67 (0.59-0.75) and 0.70 (0.61-0.78)], external test [0.69 (0.59-0.78) and 0.65 (0.55-0.76)] cohorts. The DeepMR-LACC effectively stratified patients into high- or low-risk groups, outperforming current clinical risk factors. Furthermore, proteomic profiling revealed an immunosuppressive microenvironment in the high-risk group. Finally, radioproteomics-based risk stratification showed superior prognostic performance compared to the DeepMR-LACC for PFS and OS in the radioproteomics cohort [C-indices 0.85 (0.74-0.96) and 0.85 (0.73-0.96)]. The DeepMR-LACC enabled accurate prognostic prediction and in-depth tumor microenvironment characterization for LACC, aiding personalized long-term management.
Authors
- Jingkui Tian (ORCID: https://orcid.org/0000-0001-5472-204X)
- Zijian Sun (ORCID: https://orcid.org/0000-0002-3116-2104)
- Xiaoyong Zhang (ORCID: https://orcid.org/0000-0003-3348-4956)
- Hanmei Lou (ORCID: https://orcid.org/0000-0002-3234-1673)
- Haowen Li (ORCID: https://orcid.org/0000-0003-2746-4000)
- Jiahui Ma
- Liting Shi (ORCID: https://orcid.org/0000-0002-7771-2001)
- Yue Feng (ORCID: https://orcid.org/0000-0002-5371-554X)
- Jiayu Song (ORCID: https://orcid.org/0000-0002-0138-1373)
- Qiyang Li (ORCID: https://orcid.org/0000-0003-2214-9968)
- Zhen Zhang (ORCID: https://orcid.org/0000-0001-7825-2679)
- Yihan Wang (ORCID: https://orcid.org/0000-0002-1163-4610)
- Wei Zhu
- Yuqiang Li (ORCID: https://orcid.org/0000-0003-1517-3687)
- Yunyan Zhang (ORCID: https://orcid.org/0000-0002-2196-7291)
- Fang Wang (ORCID: https://orcid.org/0009-0001-8433-1346)
- Zhao Wang
- Hui Ye (ORCID: https://orcid.org/0000-0001-7607-627X)
- Lei Shi (ORCID: https://orcid.org/0000-0003-3583-4649)
- Tao Feng (ORCID: https://orcid.org/0009-0006-9560-5441)
- Xiaojuan Lv (ORCID: https://orcid.org/0009-0007-7294-2338)
- C. Xu (ORCID: https://orcid.org/0000-0002-9021-6731)
Institutions
- Zhejiang Chinese Medical University (CN)
- Harbin Medical University (CN)
- Zhejiang University of Science and Technology (CN)
- Chinese Academy of Sciences (CN)
- University of Macau (MO)
- Zhejiang Cancer Hospital (CN)
- Third Affiliated Hospital of Harbin Medical University (CN)
- Zhejiang University of Technology (CN)
Publication Details
- Journal
- npj Precision Oncology
- Published
- 2025-12-12
- DOI
- https://doi.org/10.1038/s41698-025-01234-8
- Primary Topic
- Endometrial and Cervical Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Chinese Academy of Sciences
- Japan Society for the Promotion of Science
- Natural Science Foundation of Zhejiang Province